Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BECTON DICKINSON & COBDX · Entity 2498 | Executive Vice President | May 11, 2018 | May 14, 2018 |
| Inogen IncINGN · Entity 2083 | Director · CEO and President | September 01, 2023 | September 05, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BECTON DICKINSON & CO
Report date May 11, 2018 · Filed May 14, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,811 |
Ending reported balance
After 2018-05-11 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2018-05-11 · Exercise / conversion · Acquired 4,665 · Balance 12,476 Row 2 · 2018-05-11 · Disposition to issuer · Disposed 1,573 · Balance 10,903 F1: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $226.00 through $226.42. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Row 3 · 2018-05-11 · Sale · Disposed 3,092 · Balance 7,811 F1: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $226.00 through $226.42. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Row 4 · 2018-05-11 · Exercise / conversion · Acquired 13,735 · Balance 21,546 Row 5 · 2018-05-11 · Disposition to issuer · Disposed 6,618 · Balance 14,928 F1: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $226.00 through $226.42. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Row 6 · 2018-05-11 · Sale · Disposed 7,117 · Balance 7,811 F1: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $226.00 through $226.42. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $76.18 · Expires 2022-11-20 | Direct | 0 |
Reported balance
After 2018-05-11 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2018-05-11 · Exercise / conversion · Disposed 4,665 · Balance 0 F2: The stock appreciation rights vest in four annual installments beginning November 20, 2013. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $108.89 · Expires 2023-11-26 | Direct | 0 |
Reported balance
After 2018-05-11 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2018-05-11 · Exercise / conversion · Disposed 13,735 · Balance 0 F3: The stock appreciation rights vest in four annual installments beginning November 26, 2014. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $226.00 through $226.42. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request.
F2: The stock appreciation rights vest in four annual installments beginning November 20, 2013.
F3: The stock appreciation rights vest in four annual installments beginning November 26, 2014.
Inogen Inc
Report date September 01, 2023 · Filed September 05, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,991 |
Ending reported balance
After 2023-09-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-09-01 · Exercise / conversion · Acquired 3,686 · Balance 38,933 Row 2 · 2023-09-01 · Tax withholding · Disposed 1,942 · Balance 36,991 F1: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2023. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 4,704 |
Reported balance
After 2023-09-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-09-01 · Exercise / conversion · Disposed 1,569 · Balance 4,704 F2: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3: Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 4,234 |
Reported balance
After 2023-09-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-09-01 · Exercise / conversion · Disposed 2,117 · Balance 4,234 F2: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F4: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2023.
F2: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
F3: Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years.
F4: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2023 Filed Sep 5, 2023 22:23 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 2,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-048239 · doc4.xml · derivative · entry 4 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,234 Underlying: Common Stock · 2,117 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F4 · derivative.exercise_date: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years. F4 · derivative.expiration_date: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 22:23 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 1,569 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-048239 · doc4.xml · derivative · entry 3 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,704 Underlying: Common Stock · 1,569 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years. F3 · derivative.expiration_date: Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 22:23 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 1,942 | $6.18 | $12,001.56 |
DisclosureSEC source: 0001209191-23-048239 · doc4.xml · nonDerivative · entry 2 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,991 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2023. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 22:23 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 3,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-048239 · doc4.xml · nonDerivative · entry 1 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,933 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:45 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 2,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-034381 · doc4.xml · derivative · entry 4 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,351 Underlying: Common Stock · 2,117 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F4 · derivative.exercise_date: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years. F4 · derivative.expiration_date: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:45 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 1,568 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-034381 · doc4.xml · derivative · entry 3 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,273 Underlying: Common Stock · 1,568 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years. F3 · derivative.expiration_date: Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:45 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 1,941 | $10.37 | $20,128.17 |
DisclosureSEC source: 0001209191-23-034381 · doc4.xml · nonDerivative · entry 2 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,247 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2023. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:45 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 3,685 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-034381 · doc4.xml · nonDerivative · entry 1 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,188 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 00:41 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 13,017 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014958 · doc4.xml · derivative · entry 7 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,034 Underlying: Common Stock · 13,017 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F7 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. F7 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 00:41 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 2,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014958 · doc4.xml · derivative · entry 6 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,468 Underlying: Common Stock · 2,117 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F6 · derivative.exercise_date: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years. F6 · derivative.expiration_date: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 00:41 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 1,568 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014958 · doc4.xml · derivative · entry 5 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,841 Underlying: Common Stock · 1,568 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F5 · derivative.exercise_date: Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years. F5 · derivative.expiration_date: Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 00:41 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 8,362 | $15.56 | $130,112.72 |
DisclosureSEC source: 0001209191-23-014958 · doc4.xml · nonDerivative · entry 4 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,503 F3 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 00:41 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 16,702 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014958 · doc4.xml · nonDerivative · entry 3 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,865 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 00:41 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 3,873 | $15.56 | $60,263.88 |
DisclosureSEC source: 0001209191-23-014958 · doc4.xml · nonDerivative · entry 2 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,163 F2 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with the 2022 performance-based restricted stock award granted on March 1, 2022 and vested on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 00:41 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 7,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014958 · doc4.xml · nonDerivative · entry 1 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,036 F1 · shares: The reported securities represent shares earned and vested on March 1, 2023 based on achievement of the financial performance conditions for the 2022 fiscal year that were approved as part of the 2022 performance-based restricted stock award granted on March 1, 2022. Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 00:41 UTC | Inogen Inc INGN · Entity 2083 | GrantRestricted Stock Unit · Derivative | 70,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014958 · doc4.xml · derivative · entry 8 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,197 Underlying: Common Stock · 70,197 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F8 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2024, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. F8 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2024, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. Read SEC document |
| December 01, 2022 Filed Dec 6, 2022 00:30 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 2,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-059872 · doc4.xml · derivative · entry 4 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,585 Underlying: Common Stock · 2,117 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F4 · derivative.exercise_date: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years. F4 · derivative.expiration_date: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years. Read SEC document |
| December 01, 2022 Filed Dec 6, 2022 00:30 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 1,568 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-059872 · doc4.xml · derivative · entry 3 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,410 Underlying: Common Stock · 1,568 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years. F3 · derivative.expiration_date: Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years. Read SEC document |
| December 01, 2022 Filed Dec 6, 2022 00:30 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 1,828 | $22.89 | $41,842.92 |
DisclosureSEC source: 0001209191-22-059872 · doc4.xml · nonDerivative · entry 2 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,226 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2022. Read SEC document |
| December 01, 2022 Filed Dec 6, 2022 00:30 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 3,685 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-059872 · doc4.xml · nonDerivative · entry 1 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,054 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2022 Filed Sep 7, 2022 00:51 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 2,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-048923 · doc4.xml · derivative · entry 4 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,702 Underlying: Common Stock · 2,117 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F4 · derivative.exercise_date: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years. F4 · derivative.expiration_date: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years. Read SEC document |
| September 01, 2022 Filed Sep 7, 2022 00:51 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 1,568 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-048923 · doc4.xml · derivative · entry 3 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,978 Underlying: Common Stock · 1,568 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years. F3 · derivative.expiration_date: Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years. Read SEC document |
| September 01, 2022 Filed Sep 7, 2022 00:51 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 1,828 | $28.78 | $52,609.84 |
DisclosureSEC source: 0001209191-22-048923 · doc4.xml · nonDerivative · entry 2 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,369 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2022. Read SEC document |
| September 01, 2022 Filed Sep 7, 2022 00:51 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 3,685 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-048923 · doc4.xml · nonDerivative · entry 1 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,197 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 23:42 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 2,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034374 · doc4.xml · derivative · entry 4 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,819 Underlying: Common Stock · 2,117 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F4 · derivative.exercise_date: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years. F4 · derivative.expiration_date: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 23:42 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 1,568 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034374 · doc4.xml · derivative · entry 3 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,546 Underlying: Common Stock · 1,568 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years. F3 · derivative.expiration_date: Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 23:42 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 1,828 | $25.91 | $47,363.48 |
DisclosureSEC source: 0001209191-22-034374 · doc4.xml · nonDerivative · entry 2 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,512 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2022. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 23:42 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 3,685 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034374 · doc4.xml · nonDerivative · entry 1 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2022 Filed May 12, 2022 22:27 UTC | Inogen Inc INGN · Entity 2083 | GrantRestricted Stock Unit · Derivative | 109,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028628 · doc4.xml · derivative · entry 1 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,531 Underlying: Common Stock · 109,531 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F2 · derivative.exercise_date: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024. F2 · derivative.expiration_date: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:52 UTC | Inogen Inc INGN · Entity 2083 | GrantRestricted Stock Unit · Derivative | 39,051 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-016012 · doc4.xml · derivative · entry 7 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,051 Underlying: Common Stock · 39,051 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F7 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. F7 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:52 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 16,936 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-016012 · doc4.xml · derivative · entry 6 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,936 Underlying: Common Stock · 16,936 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F6 · derivative.exercise_date: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years. F6 · derivative.expiration_date: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:52 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Unit · Derivative | 4,705 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-016012 · doc4.xml · derivative · entry 5 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,114 Underlying: Common Stock · 4,705 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F5 · derivative.exercise_date: Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years. F5 · derivative.expiration_date: Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:52 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 10,730 | $35.21 | $377,803.30 |
DisclosureSEC source: 0001209191-22-016012 · doc4.xml · nonDerivative · entry 4 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,655 F3 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:52 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 21,641 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-016012 · doc4.xml · nonDerivative · entry 3 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,385 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:52 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 4,665 | $35.21 | $164,254.65 |
DisclosureSEC source: 0001209191-22-016012 · doc4.xml · nonDerivative · entry 2 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,744 F2 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with the 2021 performance-based restricted stock award granted on March 1, 2021 and vested on March 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:52 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 9,409 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-016012 · doc4.xml · nonDerivative · entry 1 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,409 F1 · shares: The reported securities represent shares earned and vested on March 1, 2022 based on achievement of the financial performance conditions for the 2021 fiscal year that were approved as part of the 2021 performance-based restricted stock award granted on March 1, 2021. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:05 UTC | Inogen Inc INGN · Entity 2083 | GrantRestricted Stock Unit · Derivative | 18,818 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-017182 · doc4.xml · derivative · entry 2 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,818 Underlying: Common Stock · 18,818 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years. F3 · derivative.expiration_date: Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:05 UTC | Inogen Inc INGN · Entity 2083 | GrantRestricted Stock Unit · Derivative | 16,936 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-017182 · doc4.xml · derivative · entry 1 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,936 Underlying: Common Stock · 16,936 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F2 · derivative.exercise_date: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years. F2 · derivative.expiration_date: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years. Read SEC document |
| March 01, 2021 Filed Apr 5, 2021 22:15 UTC Amendment | Inogen Inc INGN · Entity 2083 | GrantRestricted Stock Unit · Derivative | 33,872 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-025366 · doc4a.xml · derivative · entry 1 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,872 Underlying: Common Stock · 33,872 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F2 · shares: Originally filed Form 4 reported 16,936. F3 · derivative.exercise_date: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2023, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years. F4 · derivative.exercise_date: Originally filed form 4 reported incorrect vesting schedule. F3 · derivative.expiration_date: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2023, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years. F4 · derivative.expiration_date: Originally filed form 4 reported incorrect vesting schedule. F2 · derivative.underlying_shares: Originally filed Form 4 reported 16,936. F2 · balance_after: Originally filed Form 4 reported 16,936. Read SEC document |
| May 11, 2018 Filed May 14, 2018 14:02 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionStock Appreciation Rights · Derivative | 13,735 | $0.00 Strike: $108.89 | $0.00 |
DisclosureSEC source: 0001543407-18-000038 · edgar.xml · derivative · entry 8 Shabshab Nabil · CIK 0001568903 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,735 shares Expires 2023-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2014. Read SEC document |
| May 11, 2018 Filed May 14, 2018 14:02 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionStock Appreciation Rights · Derivative | 4,665 | $0.00 Strike: $76.18 | $0.00 |
DisclosureSEC source: 0001543407-18-000038 · edgar.xml · derivative · entry 7 Shabshab Nabil · CIK 0001568903 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,665 shares Expires 2022-11-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 20, 2013. Read SEC document |
| May 11, 2018 Filed May 14, 2018 14:02 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 7,117 | $226.10 | $1,609,153.70 |
DisclosureSEC source: 0001543407-18-000038 · edgar.xml · nonDerivative · entry 6 Shabshab Nabil · CIK 0001568903 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,811 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $226.00 through $226.42. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Read SEC document |
| May 11, 2018 Filed May 14, 2018 14:02 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Disposition to issuerCommon Stock | 6,618 | $226.10 | $1,496,329.80 |
DisclosureSEC source: 0001543407-18-000038 · edgar.xml · nonDerivative · entry 5 Shabshab Nabil · CIK 0001568903 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,928 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $226.00 through $226.42. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Read SEC document |
| May 11, 2018 Filed May 14, 2018 14:02 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionCommon Stock | 13,735 | $108.89 | $1,495,604.15 |
DisclosureSEC source: 0001543407-18-000038 · edgar.xml · nonDerivative · entry 4 Shabshab Nabil · CIK 0001568903 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2018 Filed May 14, 2018 14:02 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 3,092 | $226.10 | $699,101.20 |
DisclosureSEC source: 0001543407-18-000038 · edgar.xml · nonDerivative · entry 3 Shabshab Nabil · CIK 0001568903 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,811 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $226.00 through $226.42. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Read SEC document |
| May 11, 2018 Filed May 14, 2018 14:02 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Disposition to issuerCommon Stock | 1,573 | $226.10 | $355,655.30 |
DisclosureSEC source: 0001543407-18-000038 · edgar.xml · nonDerivative · entry 2 Shabshab Nabil · CIK 0001568903 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,903 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $226.00 through $226.42. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Read SEC document |
| May 11, 2018 Filed May 14, 2018 14:02 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionCommon Stock | 4,665 | $76.18 | $355,379.70 |
DisclosureSEC source: 0001543407-18-000038 · edgar.xml · nonDerivative · entry 1 Shabshab Nabil · CIK 0001568903 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2017 Filed Nov 28, 2017 14:23 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantStock Appreciation Rights · Derivative | 14,851 | $0.00 Strike: $226.28 | $0.00 |
DisclosureSEC source: 0001543407-17-000048 · edgar.xml · derivative · entry 4 Shabshab Nabil · CIK 0001568903 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,851 Underlying: Common Stock · 14,851 shares Expires 2027-11-26 F4 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2018. Read SEC document |
| November 26, 2017 Filed Nov 28, 2017 14:23 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 1,549 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-17-000048 · edgar.xml · nonDerivative · entry 3 Shabshab Nabil · CIK 0001568903 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,811 F3 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| November 25, 2017 Filed Nov 28, 2017 14:23 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 2,782 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-17-000048 · edgar.xml · nonDerivative · entry 2 Shabshab Nabil · CIK 0001568903 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,262 F2 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) vesting of the performance units referred to in footnote (1) and (B) the vesting of restricted stock units as previously reported on Table I. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.